Aging
Navigate
Submit an Article
Research Paper|Volume 13, Issue 20|pp. 23810–23830
CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancer
Back to articleFigure 2(2 of 8)
100%
Figure 2
Figure 2.GSEA results show that CCR5 is positively correlated with NF-κB pathway (A), TCR pathway (B), TH1/TH2 pathway (C), Natural killer cell up (D), immune checkpoint signature (E) and Apoptosis (F).